Jorge Avila, INPI’s president, says that INPI supports the importance of patents for society, but the Institute also helps to limit abuses of these rights
The proceedings in question relate to a mechanism established by Brazilian legislation - the pipeline. The current Industrial Property Law, published in 1996, included the pipeline to protect inventions of pharmaceutical and chemical patents which could not be protected before –Brazil did not grant patent to this types of products. Through this new mechanism, a patent holder would have a year to apply to the INPI counting from the publication of the Intellectual Property Act in 1996. The protection term of 20 years however, was to be counted from the ‘first filing’ abroad. Moreover, the validity period should not surpass 20 years after its first filing.
The Regional Court follows the same principle as other cases posted in this blog, such as: Sifrol, Persantin, Viagra,Lipitor, Gleevec, and Plavix.













Más información 





